LifeVantage Corporation (LFVN) Key Metrics
LFVN valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $75.5M
- Enterprise value
- $71.9M
- P/E (TTM)
- 15.0 10-yr median 17.8
- Forward P/E
- 37.5
- PEG ratio
- 0.36
- Price / sales
- 0.4 10-yr median 0.4
- Price / book
- 2.3 10-yr median 3.7
- EV / EBITDA
- 8.1 10-yr median 8.6
- Dividend yield
- 3.33% $0.20 a year
- Beta
- 0.71
LFVN key metrics, FY2017–FY2026
Fiscal year ended June 30, 2026 · U.S. dollarsLFVN valuation Price multiples at each fiscal year-end price.
LFVN returns How much profit the business earns on the capital it uses.
LFVN per-share figures Results divided by the shares outstanding at year-end.
LFVN financial health Debt, liquidity and how easily interest is covered.
LFVN efficiency & capital use Working capital cycle and where the cash goes.
LFVN valuation history
LFVN returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
LFVN debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
LFVN cash returned to shareholders
LFVN price vs earnings per share
LFVN key metrics
FY2017–FY2026| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $79.3M | $169.9M | $83.4M | $54.7M | $56.9M | $104.9M | $197.4M | $194.4M | $90.0M | $61.1M |
| Enterprise value | $74.2M | $161.3M | $80.1M | $46.1M | $52.4M | $99.9M | $176.4M | $177.1M | $78.8M | $57.1M |
| P/E ratio | 15.6 | 17.3 | 28.4 | 21.5 | 18.2 | 8.1 | 17.1 | 26.2 | 15.6 | 38.0 |
| Price / sales | 0.4 | 0.7 | 0.4 | 0.3 | 0.3 | 0.5 | 0.8 | 0.9 | 0.4 | 0.3 |
| Price / book | 2.4 | 4.9 | 3.2 | 1.6 | 1.8 | 2.8 | 5.9 | 7.1 | 4.1 | 4.2 |
| Price / free cash flow | 11.9 | 16.2 | 8.4 | 14.5 | 8.8 | 16.3 | 12.6 | 12.7 | 10.5 | 11.0 |
| Price / operating cash flow | 7.7 | 14.3 | 6.8 | 8.0 | 7.1 | 13.2 | 10.8 | 10.9 | 6.8 | 9.3 |
| EV / sales | 0.4 | 0.7 | 0.4 | 0.2 | 0.3 | 0.5 | 0.8 | 0.8 | 0.4 | 0.3 |
| EV / EBITDA | 8.4 | 10.5 | 10.1 | 5.9 | 6.6 | 4.9 | 8.9 | 15.5 | 7.0 | 11.1 |
| EV / free cash flow | 11.1 | 15.4 | 8.0 | 12.3 | 8.2 | 15.5 | 11.3 | 11.6 | 9.2 | 10.3 |
| Earnings yield | 6.4% | 5.8% | 3.5% | 4.6% | 5.5% | 12.3% | 5.9% | 3.8% | 6.4% | 2.6% |
| Free cash flow yield | 8.4% | 6.2% | 11.9% | 6.9% | 11.3% | 6.1% | 7.9% | 7.9% | 9.6% | 9.1% |
| Dividend yield | 3.0% | 1.2% | 8.3% | 2.9% | 0.7% | 0.4% | 0.3% | 0.4% | 0.0% | 0.0% |
| Shareholder yield (dividends + buybacks) | 5.5% | 3.1% | 17.5% | 4.8% | 16.6% | 9.0% | 6.2% | 4.4% | 1.7% | 0.0% |
| Share price at fiscal year-end | $6.24 | $13.08 | $6.42 | $4.35 | $4.35 | $7.35 | $13.52 | $12.98 | $6.37 | $4.33 |
| Per share | ||||||||||
| Revenue per share | $14.37 | $17.60 | $15.41 | $16.98 | $15.79 | $15.43 | $15.95 | $15.08 | $14.37 | $14.13 |
| Earnings per share | $0.40 | $0.75 | $0.23 | $0.20 | $0.24 | $0.90 | $0.79 | $0.50 | $0.41 | $0.11 |
| Operating cash flow per share | $0.81 | $0.91 | $0.94 | $0.54 | $0.61 | $0.56 | $1.26 | $1.19 | $0.94 | $0.47 |
| Free cash flow per share | $0.53 | $0.81 | $0.77 | $0.30 | $0.49 | $0.45 | $1.07 | $1.02 | $0.61 | $0.39 |
| Cash per share | $1.17 | $1.56 | $1.30 | $1.72 | $1.54 | $1.62 | $1.52 | $1.26 | $1.18 | $0.81 |
| Book value per share | $2.64 | $2.67 | $2.00 | $2.76 | $2.41 | $2.58 | $2.28 | $1.82 | $1.55 | $1.03 |
| Tangible book value per share | $2.37 | $2.65 | $1.98 | $2.72 | $2.37 | $2.53 | $2.22 | $1.75 | $1.47 | $0.94 |
| Dividends per share | $0.18 | $0.16 | $0.53 | $0.13 | $0.03 | $0.03 | $0.04 | $0.05 | $0.00 | $0.00 |
| Capex per share | $0.28 | $0.11 | $0.17 | $0.24 | $0.12 | $0.11 | $0.18 | $0.17 | $0.33 | $0.07 |
| Debt per share | $0.78 | $0.90 | $1.05 | $1.04 | $1.21 | $1.27 | $0.08 | $0.10 | $0.38 | $0.53 |
| Shares outstanding | 12.7M | 13.0M | 13.0M | 12.6M | 13.1M | 14.3M | 14.6M | 15.0M | 14.1M | 14.1M |
| Change in shares outstanding | −2.2% | +0.0% | +3.3% | −3.8% | −8.4% | −2.3% | −2.5% | +6.0% | +0.1% | −2.8% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | 14.9% | 32.3% | 9.7% | 7.7% | 9.1% | 36.8% | 38.2% | 30.2% | 31.6% | 12.1% |
| Return on invested capital (ROIC) | 18.7% | 40.0% | 12.0% | 10.2% | 17.1% | 59.8% | 110.1% | 74.4% | 58.7% | 20.3% |
| Return on assets (ROA) | 7.6% | 14.8% | 4.6% | 3.7% | 4.2% | 18.7% | 20.2% | 14.0% | 12.0% | 3.4% |
| Return on tangible assets | 8.7% | 13.7% | 4.9% | 3.9% | 4.4% | 16.5% | 19.9% | 13.7% | 11.5% | 3.7% |
| Free cash flow margin | 3.7% | 4.6% | 5.0% | 1.8% | 3.1% | 2.9% | 6.7% | 6.8% | 4.2% | 2.8% |
| Income quality (OCF / net income) | 2.02 | 1.21 | 4.15 | 2.69 | 2.55 | 0.62 | 1.59 | 2.39 | 2.30 | 4.10 |
| Financial health | ||||||||||
| Total debt | $9.9M | $11.7M | $13.6M | $13.1M | $15.8M | $18.2M | $1.2M | $1.5M | $5.4M | $7.4M |
| Cash & short-term investments | $14.9M | $20.2M | $16.9M | $21.6M | $20.2M | $23.2M | $22.1M | $18.8M | $16.7M | $11.5M |
| Net debt | −$5.1M | −$8.5M | −$3.3M | −$8.5M | −$4.4M | −$5.0M | −$21.0M | −$17.4M | −$11.2M | −$4.0M |
| Debt / equity | 0.29 | 0.34 | 0.52 | 0.38 | 0.50 | 0.49 | 0.04 | 0.05 | 0.25 | 0.51 |
| Debt / assets | 0.16 | 0.16 | 0.23 | 0.20 | 0.22 | 0.23 | 0.02 | 0.03 | 0.11 | 0.16 |
| Net debt / EBITDA | −0.57 | −0.55 | −0.41 | −1.09 | −0.56 | −0.24 | −1.05 | −1.52 | −0.99 | −0.78 |
| Current ratio | 1.89 | 1.87 | 1.69 | 2.26 | 1.83 | 1.91 | 1.75 | 1.65 | 1.64 | 1.52 |
| Quick ratio | 1.09 | 1.11 | 1.01 | 1.44 | 1.18 | 1.27 | 1.20 | 1.12 | 1.06 | 0.81 |
| Interest coverage | — | — | — | 21.5 | 757.5 | — | 128.9 | 29.4 | 22.6 | 7.8 |
| Working capital | $18.1M | $23.7M | $15.3M | $24.7M | $21.2M | $22.9M | $18.8M | $17.0M | $15.1M | $12.2M |
| Invested capital | $28.5M | $26.1M | $22.7M | $26.1M | $27.1M | $31.8M | $12.3M | $9.8M | $10.7M | $10.5M |
| Tangible asset value | $30.1M | $34.4M | $25.7M | $34.2M | $30.9M | $36.1M | $32.4M | $26.2M | $20.8M | $13.3M |
| Net current asset value | $9.8M | $13.6M | $3.3M | $12.8M | $7.8M | $6.1M | $18.2M | $15.1M | $9.7M | $4.8M |
| Graham number | $4.87 | $6.73 | $3.19 | $3.54 | $3.60 | $7.24 | $6.37 | $4.50 | $3.77 | $1.62 |
| Graham net-net per share | −$0.26 | −$0.30 | −$0.57 | −$0.04 | −$0.53 | −$0.54 | $0.37 | $0.01 | −$0.27 | −$0.66 |
| Capital allocation | ||||||||||
| Dividends paid | $2.3M | $2.1M | $6.9M | $1.6M | $378,000 | $378,000 | $653,000 | $701,000 | $0 | $0 |
| Share buybacks (net) | $2.0M | $3.1M | $7.7M | $1.0M | $9.1M | $9.1M | $11.7M | $7.8M | $1.5M | $0 |
| Dividend payout ratio | 46.2% | 21.1% | 236.3% | 62.4% | 12.1% | 2.9% | 5.7% | 9.4% | 0.0% | 0.0% |
| Dividends + buybacks / free cash flow | 65.8% | 49.6% | 146.6% | 69.4% | 147.1% | 147.1% | 78.6% | 55.8% | 17.4% | 0.0% |
| Capex / revenue | 2.0% | 0.6% | 1.1% | 1.4% | 0.7% | 0.7% | 1.2% | 1.1% | 2.3% | 0.5% |
| Capex / operating cash flow | 34.9% | 11.5% | 18.4% | 44.9% | 19.2% | 19.2% | 14.6% | 14.1% | 35.1% | 16.0% |
| Capex / depreciation | 1.29 | 0.43 | 0.63 | 0.86 | 0.30 | 0.47 | 0.53 | 1.32 | 3.51 | 0.64 |
| Stock-based compensation / revenue | 1.3% | 2.5% | 1.6% | 1.5% | 0.9% | 0.8% | 2.1% | 2.4% | 1.6% | 1.3% |
| R&D / revenue | — | — | 0.3% | 0.3% | 0.3% | 0.3% | 0.4% | 0.5% | 0.6% | 0.6% |
| SG&A / revenue | 74.2% | 30.3% | 77.1% | 77.7% | 77.9% | 74.7% | 77.1% | 78.9% | 77.8% | 81.0% |
| Efficiency | ||||||||||
| Days sales outstanding | 6.9 | 5.7 | 4.7 | 5.9 | 8.0 | 5.4 | 4.6 | 4.7 | 4.3 | 3.5 |
| Days of inventory on hand | 164.1 | 145.3 | 137.1 | 136.9 | 156.2 | 143.5 | 132.9 | 131.6 | 158.2 | 227.4 |
| Days payables outstanding | 45.5 | 46.2 | 46.3 | 51.1 | 74.3 | 58.3 | 47.1 | 43.2 | 45.4 | 75.0 |
| Cash conversion cycle (days) | 125.5 | 104.9 | 95.5 | 91.7 | 89.9 | 90.7 | 90.4 | 93.1 | 117.1 | 155.9 |
| Receivables turnover | 52.78 | 63.56 | 78.27 | 61.47 | 45.59 | 67.00 | 78.79 | 77.65 | 85.29 | 105.02 |
| Payables turnover | 8.02 | 7.91 | 7.88 | 7.14 | 4.91 | 6.26 | 7.75 | 8.45 | 8.05 | 4.87 |
| Inventory turnover | 2.22 | 2.51 | 2.66 | 2.67 | 2.34 | 2.54 | 2.75 | 2.77 | 2.31 | 1.60 |
| Asset turnover | 2.72 | 3.46 | 3.17 | 3.12 | 2.76 | 3.20 | 4.08 | 4.25 | 4.22 | 4.18 |
| Average receivables | $3.5M | $3.6M | $2.6M | $3.5M | $4.5M | $3.3M | $3.0M | $2.9M | $2.4M | $1.9M |
| Average payables | $5.1M | $5.7M | $5.3M | $6.1M | $7.8M | $6.1M | $4.9M | $4.5M | $4.3M | $6.9M |
| Average inventory | $18.4M | $17.9M | $15.6M | $16.3M | $16.3M | $15.0M | $13.8M | $13.7M | $15.1M | $20.8M |
| Intangibles / total assets | 5.7% | 0.3% | 0.5% | 0.7% | 0.8% | 0.9% | 1.4% | 1.8% | 2.2% | 2.8% |
Computed from LFVN's annual financial statements (latest annual report filed August 27, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
LFVN valuation and financial ratios
At the end of fiscal 2026 (June 30, 2026), LifeVantage traded at 15.6 times earnings, against a 10-year median of 17.8. Based on the latest twelve months, the trailing P/E is 15.0 and the forward P/E is 37.5. LifeVantage earned a return on equity of 14.9% and a return on invested capital of 18.7% in fiscal 2026. It ended the year with $9.9 million of debt and $14.9 million in cash and short-term investments, a net cash position of $5.1 million. It returned $4.4 million to shareholders: $2.3 million in dividends and $2.0 million in share buybacks, 66% of free cash flow. The share count fell 10.0% from 14.1M to 12.7M over 9 years.
See the LFVN income statement, the LFVN chart for price history, or the LFVN stock overview for the latest quote and news.
LFVN key metrics FAQ
What is LifeVantage's P/E ratio?
LifeVantage's trailing P/E ratio is 15.0 based on the last twelve months of earnings (as of October 18, 2026), and its forward P/E is 37.5. At the end of fiscal 2026 it was 15.6, compared with a 10-year median of 17.8.
What is LifeVantage's EV/EBITDA?
LifeVantage's enterprise value was 8.4 times EBITDA at the end of fiscal 2026 (enterprise value $74.2 million, EBITDA $8.8 million); the current EV/EBITDA is 8.1.
What is LifeVantage's return on equity?
LifeVantage's return on equity (ROE) was 14.9% in fiscal 2026: net income of $5.1 million on average shareholders' equity of $34.1 million.
What is LifeVantage's ROIC?
LifeVantage's return on invested capital was 18.7% in fiscal 2026, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does LifeVantage have?
LifeVantage had total debt of $9.9 million at the end of fiscal 2026, a debt-to-equity ratio of 0.29 and more cash than debt.
What is LifeVantage's dividend yield?
LifeVantage's forward dividend yield is 3.33%. LifeVantage paid $2.3 million in dividends in fiscal 2026 ($0.18 per share), a payout ratio of 46.2%.
Does LifeVantage buy back its shares?
Yes. LifeVantage spent $2.0 million on net share repurchases in fiscal 2026 Shares outstanding changed −2.2% over the year, to 12.7M..
What is LifeVantage's free cash flow yield?
LifeVantage generated $6.7 million of free cash flow in fiscal 2026, a free cash flow yield of 8.4% on its market value at year-end ($79.3 million).
What is LifeVantage's current ratio?
LifeVantage's current ratio was 1.89 at the end of fiscal 2026: current assets were 1.89 times current liabilities.